Intervention
Regadenoson
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 7 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
7 shownAllograft Dysfunction in Heart TransplantNCT03102125 · 2019-10-01
RECRUITINGNew MRI Methods Applied to Heart Failure With Preserved Ejection Fraction (HFpEF)NCT04600115 · 2017-03-03
RECRUITINGStress Test in Detecting Heart Damage in Premenopausal Women With Stage I-III Breast CancerNCT03505736 · 2018-06-21
COMPLETEDRegadenoson for Acute Vasoreactivity Testing in Pulmonary HypertensionNCT02220634 · 2014-08-01
TERMINATEDA Study of the Safety and Tolerance of Regadenoson in Subjects With Asthma or Chronic Obstructive Pulmonary DiseaseNCT00862641 · 2009-04-01
COMPLETEDEffects of Body Mass Index on the Hyperemic Response to RegadenosonNCT00859833 · 2009-02-01
COMPLETEDComparison of Dobutamine and Regadenoson Stress Cardiac Magnetic Resonance (MR)NCT00763035 · 2009-01-01
TERMINATEDCommon conditions
Asthma2Coronary Artery Disease2Anatomic Stage I Breast Cancer AJCC v81Anatomic Stage IA Breast Cancer AJCC v81Anatomic Stage IB Breast Cancer AJCC v81Anatomic Stage II Breast Cancer AJCC v81Anatomic Stage IIA Breast Cancer AJCC v81Anatomic Stage IIB Breast Cancer AJCC v81Anatomic Stage III Breast Cancer AJCC v81Anatomic Stage IIIA Breast Cancer AJCC v81Anatomic Stage IIIB Breast Cancer AJCC v81Anatomic Stage IIIC Breast Cancer AJCC v81Angina1Chronic Obstructive Pulmonary Disease (COPD)1Decreased Vascular Flow1Endothelial Dysfunction1Heart Transplant Failure and Rejection1MRI Scans1Obesity1Premenopausal1Prognostic Stage I Breast Cancer AJCC v81Prognostic Stage IA Breast Cancer AJCC v81Prognostic Stage IB Breast Cancer AJCC v81Prognostic Stage II Breast Cancer AJCC v81Prognostic Stage IIA Breast Cancer AJCC v81
Leading sponsors
Trial status mix
COMPLETED3
RECRUITING2
TERMINATED2
Phase mix
EARLY_PHASE12
NA2
PHASE42
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.